Author:
Flores Marcela Rodriguez,Zuniga Sylvana Stephano
Publisher
Springer International Publishing
Reference93 articles.
1. Aigner, M., Treasure, J., Kaye, W., Kasper, S., & WFSBP Task Force on Eating Disorders. (2011). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. The World Journal of Biological Psychiatry, 12(6), 400–443. https://doi.org/10.3109/15622975.2011.602720
2. Andries, A., Frystyk, J., Flyvbjerg, A., & Støving, R. K. (2014). Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial. International Journal of Eating Disorders, 47(1), 18–23.
3. Andries, A., Frystyk, J., Flyvbjerg, A., & Støving, R. K. (2015a). Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial. Growth Hormone & IGF Research, 25(5), 247–252.
4. Andries, A., Gram, B., & Støving, R. K. (2015b). Effect of dronabinol therapy on physical activity in anorexia nervosa: A randomised, controlled trial. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity, 20(1), 13–21.
5. Apfelbaum, M., & Mandenoff, A. (1981). Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet. Pharmacology Biochemistry and Behavior, 15(1), 89–91. https://doi.org/10.1016/0091-3057(81)90344-0
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献